S

Salarius Pharmaceuticals

D
SLRX
USD
-0.08
(-5.2288%)
Market Closed
231.000
حجم التداول
-214.48
الربح لكل سهم
-
العائد الربحي
-0.166094
P/E
2,089,677.65
حجم السوق
اليوم
-3.9735%
1 اسبوع
-0.685%
1 شهر
1.399%
6 اشهر
-62.240%
12 اشهر
-76.522%
بداية السنة
-71.899%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
197
عدد التوصيات
3

Title:
Salarius Pharmaceuticals Inc.

Sector:
Healthcare
Industry:
Biotechnology
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
هل تحتاج مساعدة او لديك استفسار؟